Give me a deep insight notes about the topic opp i have to write it in my notes book from basics
Asking for Preferences
Opp means organophosphate poisoning
Reading File
Finding Sources
Finding Sources
Searching PubMed
"organophosphate poisoning"[MeSH Terms] AND management
Reading File
Reading File
Reading File
Reading File
Reading File
Searching Images
organophosphate poisoning cholinergic toxidrome mechanism acetylcholinesterase
Reading File
Reading File
Loading Image
Reading File
I now have all the information needed to write comprehensive, notebook-style notes on OPP. Let me compile everything.
📝 ORGANOPHOSPHATE POISONING (OPP) - Deep Insight Notes
1. INTRODUCTION & BACKGROUND
- Organophosphates (OPs) are a class of insecticides (and chemical warfare agents) that work by inhibiting cholinesterase enzymes.
- Since 1945, approximately 15,000 individual OP compounds have come into use.
- Common agents: parathion, malathion, diazinon, chlorpyrifos, acephate, dichlorvos
- Chemical warfare nerve agents (sarin, VX, Novichok) share the same mechanism.
- Most common cause of OPP worldwide = deliberate self-poisoning (suicide attempts)
- Accidental exposures: agricultural/industrial sprays, food contamination, pet flea-dip products
-
150,000 pesticide poisoning deaths occur per year globally; insecticides account for the majority.
2. MECHANISM OF TOXICITY (Pathophysiology)
Key Enzyme: Acetylcholinesterase (AChE)
- AChE normally breaks down acetylcholine (ACh) at nerve synapses.
- OPs irreversibly bind and phosphorylate AChE → AChE is inactivated → ACh accumulates.
- Two forms of cholinesterase are affected:
- True/RBC AChE - found in erythrocytes, nerve tissue, skeletal muscle
- Plasma cholinesterase (pseudocholinesterase/BuChE) - found in serum, liver, pancreas, heart
"AGING" - The Critical Concept
- After OP binds to AChE, a process called aging occurs = a permanent, irreversible conformational change where OP becomes covalently locked to the enzyme.
- Time to aging varies: minutes to >24 hours depending on the agent.
- Once aging occurs, no antidote (oxime) can restore the enzyme - new enzyme must be synthesized (takes weeks).
- Antidotes are ONLY effective BEFORE aging!
ACh Accumulation → Receptor Overstimulation
ACh builds up at ALL cholinergic synapses:
| Location | Receptor Type | Effect |
|---|---|---|
| Postganglionic parasympathetic nerve endings | Muscarinic (M) | SLUDGE/Killer B's |
| Autonomic ganglia (sympathetic + parasympathetic) | Nicotinic (N) | HTN, tachycardia |
| Neuromuscular junction | Nicotinic (N) | Fasciculations → paralysis |
| CNS | Both M + N | Seizures, coma |
3. CLINICAL FEATURES - The Cholinergic Toxidrome
Mnemonic 1: SLUDGE (Muscarinic effects)
| Letter | Symptom |
|---|---|
| S | Salivation |
| L | Lacrimation |
| U | Urination |
| D | Defecation / Diarrhea |
| G | GI cramps |
| E | Emesis |
Mnemonic 2: DUMBELS (Muscarinic - complete version)
D - Diarrhea/Diaphoresis | U - Urination | M - Miosis | B - Bradycardia/Bronchorrhea/Bronchospasm (the "Killer B's") | E - Emesis | L - Lacrimation | S - Salivation
Nicotinic Effects (NMJ + Sympathetic ganglia):
- Muscle: Fasciculations, weakness, flaccid paralysis (diaphragm → respiratory arrest)
- Sympathetic: Tachycardia, hypertension, mydriasis, sweating
⚠️ Note: The heart rate in OPP can be VARIABLE - bradycardia (muscarinic dominance) OR tachycardia (nicotinic/sympathetic dominance). Miosis is the classic finding but mydriasis can occur.
CNS Effects:
- Anxiety, restlessness, delirium
- Seizures (benzodiazepine-responsive)
- Coma
- Respiratory center depression
The "Killer B's" = Primary cause of death:
- Bradycardia → cardiac arrest
- Bronchorrhea → airway flooding
- Bronchospasm → airflow obstruction
Pulmonary edema (separate from bronchorrhea!):
- Results from inflammatory mediators + increased vascular permeability
- Do NOT confuse with bronchorrhea/bronchospasm
4. THREE CLINICAL SYNDROMES IN OPP
| Syndrome | Timing | Features | Atropine/2-PAM response |
|---|---|---|---|
| Acute cholinergic crisis | 0-24 h of exposure | Classic SLUDGE/DUMBELS | Yes - responds well |
| Intermediate Syndrome (IMS) | 24-96 h after acute phase | Proximal limb weakness, neck flexors, cranial nerve motor palsies, respiratory paralysis | ❌ Does NOT respond |
| OPIDN (Organophosphate-Induced Delayed Neuropathy) | 2-5 weeks later | Distal symmetrical sensorimotor polyneuropathy (predominantly motor), muscle atrophy, then upper motor neuron signs | ❌ Does NOT respond |
⚠️ Intermediate Syndrome is a major killer - respiratory paralysis can be fatal; requires mechanical ventilation. The agent most associated with OPIDN is TOCP (triorthocresyl phosphate).
5. DIAGNOSIS
Clinical Diagnosis
- Most important: history of OP exposure + signs of cholinergic toxidrome
- Most symptomatic within first 8 hours; almost all within 24 hours
- Classic presentation: miosis + bradycardia + bronchospasm + muscle fasciculations
Laboratory Tests
| Test | What it shows | Timing of change |
|---|---|---|
| Plasma cholinesterase (BuChE) | Decreases FIRST in acute poisoning | Recovers in 4-6 weeks |
| RBC/Erythrocyte AChE | More specific; decreases in chronic exposure even when plasma is normal | Recovers in up to 12 weeks |
| ABG / acid-base | Metabolic acidosis = poor prognosis | - |
| Blood glucose | Both hyper- and hypoglycemia = increased mortality | - |
| ECG | QTc prolongation, arrhythmias | - |
⚠️ Do NOT wait for lab confirmation before treating if clinical toxidrome is present.
Differential Diagnosis
- Carbamates (same mechanism, but reversible, no aging - generally milder)
- Nicotine poisoning
- Cholinomimetics (pilocarpine, rivastigmine)
- Bacterial/viral gastroenteritis (early)
- Inferior MI with pulmonary edema (vagal response)
- Myasthenia gravis
- Thyroid storm / Phaeochromocytoma (sympathomimetic mimicry)
6. MANAGEMENT (ABCDE + Antidotes)
Step 1: DECONTAMINATION (First priority before anything else!)
- Remove all clothing and destroy it (dermal absorption is common and significant)
- Flush skin with copious water (providers must wear PPE - risk of secondary contamination from clothing/splashes)
- Dry decontamination alternatives: flour, sand, bentonite, military resins
- Eyes: irrigate with normal saline
- GI: activated charcoal if ingested, airway is secure, within 1 hour
Step 2: AIRWAY & SUPPORTIVE CARE
- Highest priority - bronchospasm + bronchorrhea + respiratory muscle paralysis = LETHAL combination
- Early intubation if respiratory failure
- Suction secretions aggressively
- Avoid succinylcholine (AChE inhibited → prolonged paralysis; use rocuronium instead)
- Benzodiazepines for seizures (first line)
Step 3: ANTIDOTE 1 - ATROPINE (Muscarinic blocker)
| Feature | Details |
|---|---|
| Mechanism | Competitive antagonist at muscarinic receptors - dries secretions, reverses bradycardia |
| DOES NOT act at nicotinic receptors | Will NOT reverse muscle fasciculations or paralysis |
| Dose (adults) | 2-4 mg IV bolus; repeat every 5-10 min |
| Dose (severe) | 10-20 mg in first hour; escalate rapidly |
| Pediatric dose | 0.02-0.05 mg/kg IV |
| Endpoint of atropinization | Drying of respiratory secretions + ease of breathing + normal respiratory rate |
| NOT the endpoint | Heart rate, pupil size, or skin dryness (overcorrection leads to anticholinergic toxidrome) |
| Maintenance | 10-20% of total cumulative dose per hour as infusion |
⚠️ Tachycardia and mydriasis during atropine therapy are NOT reasons to stop. Doses may exhaust hospital supplies - plan ahead!
Step 4: ANTIDOTE 2 - PRALIDOXIME (2-PAM) - Oxime
| Feature | Details |
|---|---|
| Mechanism | Binds to the OP-AChE complex → displaces OP → AChE resumes function |
| Only effective BEFORE aging | Must be given EARLY |
| Indications | Respiratory depression/failure, fasciculations, seizures, dysrhythmias, hemodynamic instability, or large/repeated atropine doses needed |
| Dose (adult) | 1-2 g IV (25-50 mg/kg in children) over 30 min; can repeat hourly based on response |
| Alternative dosing | 2 g bolus → 500 mg/h infusion for up to 7 days |
| Route | IV preferred; IM available (military autoinjectors) |
| Endpoint | Improved mental status, respiratory rate, heart rate, decreased secretions |
Other available oximes worldwide: TMB-4, Toxogonin, methoxime, HI-6 (pralidoxime is US standard).
Step 5: BENZODIAZEPINES for seizures
- Diazepam or lorazepam IV - first-line for OP-induced seizures
- Phenobarbital second line
- Phenytoin is ineffective for OP-induced seizures
No role for:
- Hemodialysis or other enhanced elimination - OPs are highly lipid-soluble and tissue-bound; no benefit from extracorporeal removal.
7. DISPOSITION
| Clinical severity | Disposition |
|---|---|
| Asymptomatic/minimally symptomatic, normal or mildly decreased ChE, tolerating orally | Observe 6 hours, discharge with close follow-up |
| Significant symptoms (seizures, respiratory compromise, depressed ChE) | ICU admission |
| Moderate poisoning | Monitored ward |
- Most respond within 48 hours with pralidoxime (AChE levels rise).
- Fat-soluble OPs may cause toxicity for weeks (prolonged pralidoxime infusion needed).
- Recovery (if no anoxic brain injury + early treatment) typically in ~10 days.
- Patients may have rebound toxicity days after apparent recovery - watch closely.
8. CARBAMATES vs ORGANOPHOSPHATES (Key comparison)
| Feature | Organophosphates | Carbamates |
|---|---|---|
| Enzyme binding | Irreversible (phosphorylation + aging) | Reversible (spontaneous hydrolysis in hours) |
| Severity | Generally more severe | Generally milder, self-limiting |
| Duration | Days to weeks | Hours |
| Pralidoxime (2-PAM) | Required | Generally not needed (some say avoid in carbamates) |
| Atropine | Required | Required |
| Aging | Yes - once aged, no antidote works | No aging |
9. QUICK MEMORY SUMMARY TABLE
| Topic | Key Point |
|---|---|
| MOA | OP inhibits AChE irreversibly → ACh accumulates |
| Toxidrome | Cholinergic crisis (SLUDGE/DUMBELS + Killer B's) |
| Primary cause of death | Respiratory failure (bronchorrhea + bronchospasm + diaphragm paralysis) |
| Miosis | Most consistent sign (but can have mydriasis in nicotinic dominance) |
| Aging | Irreversible binding - limits oxime efficacy |
| Antidote 1 | Atropine - blocks muscarinic effects ONLY |
| Antidote 2 | Pralidoxime (2-PAM) - regenerates AChE (before aging!) |
| Seizure drug | Benzodiazepines (phenytoin is INEFFECTIVE) |
| Succinylcholine | AVOID (prolonged paralysis) |
| Intermediate Syndrome | 24-96 h; proximal weakness + respiratory paralysis; no response to atropine |
| Delayed neuropathy (OPIDN) | 2-5 weeks; motor > sensory polyneuropathy; no antidote |
| Lab markers | Plasma ChE (falls first), RBC AChE (more specific) |
10. CLINICAL PEARL BOX
Pearl 1: The "endpoint of atropinization" is DRY SECRETIONS, NOT a heart rate target.
Pearl 2: Give atropine FAST and in BIG doses in severe OPP. Clinicians often under-dose. Start at 2-4 mg IV and double every 5 min if no response.
Pearl 3: Pralidoxime must be given EARLY - before aging locks the OP-enzyme bond permanently.
Pearl 4: In OPP, tachycardia does NOT mean stop atropine - it may be from nicotinic stimulation, not anticholinergic overdose.
Pearl 5: Pulmonary edema in OPP is NOT the same as bronchorrhea - they require different treatment approaches.
Pearl 6: Succinylcholine is contraindicated for RSI in OPP. Use rocuronium instead.
Sources:
- [Rosen's Emergency Medicine, 9th Ed.](Rosen's Emergency Medicine - Concepts and Clinical Practice, Chapter 152)
- [Tintinalli's Emergency Medicine, A Comprehensive Study Guide](Tintinalli's Emergency Medicine, Chapter 201 - Pesticides)
- [Adams and Victor's Principles of Neurology, 12th Ed.](Chapter: Phosphorus and Organophosphate Poisoning)
- Recent reviews: Advances in Detection and Management of OPP (2025) and OPP: Review of Prognosis and Management (2024)
This is a shared conversation. Sign in to Orris to start your own chat.